Innovation Pharmaceuticals Inc (IPIX)

[Whoops]

Brilacidin sales=Daptomycin+Vancomycin market penetration will be 100% for Brilacidin for those doctors that know of it. Brilacidin surpasses efficacy of both especially Vancomycin and beats both in dosing duration. One day dose provided by Brilacidin will save millions for hospitals and insurance companies. They should not have a hard time accepting this. The only way Brilacidin does not capture all of Vancomycin market in ABSSSI too is if it is priced out of it which maybe difficult to do when you price in multiple hospital visits required for Vancomycin and of course Daptomycin too.

One cannot even get a 1 day antibiotic for an ear ache! The only thing we got to watch out for here for is Polymedix syndrome caused by acute exposure to Brilacidin and the development of extreme arrogance it eventually leads one to try signing the checks to creditors with the signature "amazing drug". =-) IMO


Here is a summary evaluation report from Roth Capital for Polymedix back in 2010. Apologies if this has already been posted.
http://www.investorsinsight.com/blogs/steve_cook_on_disciplined_investing/pages/more-bs-from-obama-monday-morning-chartology-update-on-polymedix-10-bagger.aspx